Long Again9 times tested the bottom now. This looks like a bottom building. After a 2 month's decline we ave reached the October low again.
If there won't be another low today we may see a rebound.
Key facts today
886.871 ARS
107.47 B ARS
17.63 T ARS
About Merck & Company, Inc.
Sector
CEO
Robert M. Davis
Headquarters
Rahway
Website
Founded
1891
ISIN
ARDEUT110277
FIGI
BBG000FSRB61
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Merck & Co., Inc. | Chart & Forecast SummaryKey Indicators on Trade Set Up in General
1. Push Set Up
2. Range Set up
3. Break & Retest Set Up
Active Sessions on Relevant Range & Elemented Probabilities;
London(Upwards) - NYC(Downwards)
Conclusion | Trade Plan Execution & Risk Management on Demand;
Overall Consensus | Sell
Looking for a leap on MRK.🔉Sound on!🔉
Thank you as always for watching my videos. I hope that you learned something very educational! Please feel free to like, share, and comment on this post. Remember only risk what you are willing to lose. Trading is very risky but it can change your life!
MerkThe stock Mark presents an excellent opportunity for traders with a favorable risk-benefit ratio. It is currently at a strong demand zone, and there is a bullish shark harmonic pattern that aligns with this demand area, along with the 200-day moving average. This is a strong entry point near 100$, w
MRK-NYSE longterm view"Merck reported a mixed third quarter update on Thursday, cutting guidance even as earnings topped market expectations." according to barron^s.
However, the balance sheet is still solid and MRK entered an area where it presents a good Buy opportunity especially for Dividend portfolio's that want a
Engulfing BottomThe last 3 days we are not getting a new low. Instead the candles are very small and remain withing the seize of the body of the last big red candle.I see this a a strog sign of a bottom.
Merck & Co., Inc. (NYSE: MRK)1. Financial Performance
Q3 2024 Results: Merck reported strong Q3 earnings with worldwide sales of $16.7 billion, reflecting a 4% year-over-year increase. This performance was driven by growth in its oncology and vaccines divisions, particularly from products like Keytruda and Gardasil. The compan
MRK eyes on $111.22: cool number plus a MAJOR landmarkMRK testing a fib that is now clear to everyone.
Break and Retest is the signal to be looking for.
Rejection would make us look at the fibs below.
$ 111.22 is the exact level of interest.
$ 109.61 would make for a good StopLoss.
$ 116.51 will be first target for some profits.
=====================
MRK potential Buy setupReasons for bullish bias:
- Price bounced from the weekly trendline
- Strong weekly bullish closing
- Price is at horizontal support
- No divergence
Here are the recommended trading levels:
Entry Level(CMP): 117.07
Stop Loss Level: 108.81
Take Profit Level 1: 125.33
Take Profit Level 2: 133.00
Take
nice cash flow growing a little bit, it is a buyGreen candle breaks out a ascendent triangule for this stock
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
MRK3671638
Schering-Plough Corporation 6.55% 15-SEP-2037Yield to maturity
5.21%
Maturity date
Sep 15, 2037
Explore more bonds
